drugset / Trial / NCT00891150

Oxytocin to Decrease Blood Loss During Cesarean Section

NCT00891150

RandomizedParallel-groupTriple-blindPrevention

Summary

The goal of this study is to determine the best dose of a drug called oxytocin, that is usually used to stop bleeding during a delivery, when used during a cesarean delivery. It will be administered during cesarean section in order to decrease the amount blood loss. The investigators are proposing to have 3 groups of subjects each given a different safe dose of oxytocin and then to assess the effectiveness of each regimens on the amount blood lost during cesarean sections.This will let use know which is the best lowest dose needed.

Timeline

Start
2012-07
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 20 iu Intravenous
Comparator Oxytocin Peptide 30 iu Intravenous
Comparator Oxytocin Peptide 40 iu Intravenous

Indications

No indication recorded.